Studies on the Pathogenesis of Atherosclerosis [Abridged] by Professor Kenneth W Walton MD PhD (Department ofExperimental Pathology, University ofBirmingham) Numerous theories have been propounded in the past to account for the occurrence of lipid in atherosclerotic lesions. The 'classical' hypothesis was that of Virchow (1862) who suggested that the lipids were derived from the plasma by 'imbibition' or 'insudation'. Virchow also postulated that a mucous substance in the arterial wall might play some part in atherogenesis. But the precise form in which lipid is transported into the lesions was undefined.
When it was shown by Anitschkow (1933) that the addition of cholesterol to the diet of the rabbit induced lipid-filled arterial lesions (preceded and accompanied by hypercholesterolemia) attention was further directed to the plasma lipids. Initially, it was not realized that cholesterol does not circulate in the free state but that it is bound to proteins in various forms.
Recent findings suggest that, of the various vehicles for cholesterol and lipids present in plasma, the low-density (beta) lipoproteins (LDL) rank highest in importance in the pathogenesis of atherosclerosis. This evidence may be summarized as follows:
(1) Differences in serum LDL levels with age and sex, in subjects in apparently good health, parallel differences in the incidence of atherosclerosis with age and sex (Walton & Scott 1964) .
(2) Differences in serum LDL levels between the sexes in adults are accompanied by corresponding differences in the distribution and turnover of LDL , Walton et al. 1965 .
(3) In diseases characterized by hyperlipidemia and a high incidence of atherosclerosis, altered concentration of serum lipids is almost invariably reflected in elevation of LDL levels, but only rarely in alteration of high-density lipoprotein (HDL) levels (Cornwell 1967 ).
(4) Metabolic studies in hyperlipidemias (whether primary or secondary) have shown an increase of the total exchangeable pool of LDL, reflected in increases of both intravascular and extravascular pools, regardless of the mechanism of alteration of metabolism of the lipoprotein (Walton 1966). (5) In cases in which LDL, radioactively labelled in the protein moiety, has been administered, in vivo, it has been established at autopsy that atherosclerotic vessels had accumulated radio- Fig 1. x 27-5 activity at a higher level, per gram of tissue, than other organs , Scott & Winterbourn 1967 . These observations suggest that circulating LDL is incorporated into the vessel wall.
(6) Confirmation of the incorporation of LDL into atherosclerotic lesions has also been obtained at a histological level (Figs 1 and 2) using the technique of immunofluorescence (Watts 1959 , Woolf & Pilkington 1965 , Kao & Wissler 1965 , Walton 1966 , Walton & Williamson 1968 . Material antigenically related to fibrinogen has also been demonstrated in some plaques but no specific localization of other plasma proteins (including HDL) has been found in early arterial plaques.
It is now well established that plasma proteins permeate the walls of the aorta and of arteries (Mancini et al. 1962 , Duncan et al. 1962 ). The Section ofPathology evidence listed above suggests that during the passage of plasma through the intimal connective tissue gel, LDL and (to a lesser extent) fibrinogen show a particular propensity to be retained selectively in the gel, while other plasma proteins are not retained. The selective retention of LDL and fibrinogen in the intima has been suggested to be:
(a) Secondary to changes in the tunica media, due to (i) scarring of the muscularis media (Wilens & McCluskey 1954) ; (ii) blockage of fenestrations in the internal elastic lamina (Gofman & Young 1963 , Lendrum 1964 ; (iii) enzymic medial defects due to anoxia (Adams et al. 1962 ); or (b) Failure of lipids to permeate the intima because of a 'molecular sieving' effect of the intimal connective tissue gel (Adams 1967) ; or (c) Interaction of LDL and fibrinogen with the acidic mucopolysaccharides ofthe intirha (Amenta & Waters 1960 , Gero et al. 1961 .
Lipid infiltration in valves on the left side of the heart resembles that in arteries, not only in morphology and time-relations of development, but also in that LDL can be shown, by immunofluorescence, to be once again the main vehicle for lipid and cholesterol deposited in subendothelial tissues (Walton & Williamson 1969) . But the valves lack a muscularis media. It must be concluded therefore that atherosclerosis of these valves cannot be secondary to the 'dammingback' of plasma (i.e. 'plasmatic vasculosis', Lendrum 1963) because of a mechanical barrier as postulated in (a) above. It also seems unlikely that this is an adequate mechanism to explain lipid accumulation in arteries. This is because the postulated process would be expected to produce an accumulation of all the protein components of plasma, including HDLwhereas this and other plasma proteins show no selective localization.
In this connexion, no specific localization in the substance of mitral or aortic valves was found of a2Mor -M-macroglobulins (Walton & Williamson 1969) . These plasma proteins exceed the molecular size of fibrinogen and approximate to the molecular size of LDL. This suggests that no significant 'molecular sieving' of molecules of this range of size (as-postulated in (b) above) occurs in the intimal gel.
LDL is found only in the valves on the left side of the heart, which are like arteries, and not in valves on the right side, which are like veins. This suggests that hydrodynamic pressure is important in determining the distribution of lesions. The apparent direction of infiltration (Figs 3 and 4) suggests that LDL is actually forced into the substance of affected valves. The 'peri-fibrous' distribution of LDL on the surface of collagen and elastic fibres in valves and arteries (Walton & Williamson 1968 ) is consistent with selective interaction with the acid mucopolysaccharides which are associated with these fibres, as postulated in (c) above.
Discussion
The evidence reviewed suggests that the lipid in atherosclerotic lesions originates mainly from plasma low-density lipoproteins and is retained along with fibrinogen in the arterial wall because of interaction of these proteins with components of the wall during the passage of plasma through 4 the wall. The selective retention of these two proteins in the connective tissue gel may serve as a fibrogenic stimulus. Cholesterol derived from the degradation of LDL would certainly serve as a sclerogenic agent and would thereby account for the known method of progression of uncomplicated plaques. This concept of the mechanism of initiation of atherosclerosis is clearly only an extension and restatement of the classical Virchow hypothesis, validated with the use of modem techniques. The correlations, to which earlier allusion was made, between serum concentrations of LDL (as affected by age, sex, dietary habits, certain diseases, &c.) and the incidence of atherosclerosis are clearly explicable in terms of this mechanism. But it is clear that for a complete understanding of this form of arterial disease, account must also be taken of certain other considerations. The topographical distribution of lesions in their characteristic nodular and discontinuous fashion cannot be explained in terms of plasma changes alone.
Reference has already been made to intraarterial pressure as a localizing factor. It is evident that hypertension, by increasing the volume of plasma 'ultrafiltered' through the arterial wall, might be expected to produce a functionally similar result, even where the plasma concentration of LDL is normal, to that seen in association with hyperlipoproteinemia. The possible influences of localized alteration of endothelial permeability and of alteration of composition of the components of the intimal connective tissue gel, as other localizing factors, have been discussed elsewhere (Walton 1969 The measurement of the total body content of certain elements by neutron activation analysis was shown to be feasible in the living human subject by Anderson et al. (1964) . We have developed a system of whole-body neutron activation analysis optimized for the measurement of total body sodium and calcium. The system has been proven by a series of studies with inanimate phantoms, cadavers and normal volunteers (Chamberlain et al. 1968 a, b) . More recently studies have been undertaken on a number of patients with well-defined bone disease. Several elements are susceptible to estimation by the technique, including chlorine, potassium and possibly nitrogen, but we judged sodium and particularly calcium to be of the greatest immediate clinical interest and potential value. By estimating total body calcium it should be possible to study generalized (metabolic) bone disease by a more sensitive technique than any other yet available, since 96 % of body calcium is within the skeleton.
